eric topol glp-1 The Big Trial of a

12% average weight loss at 12 months for Teladoc Health members on a GLP-1 1 92% of Weight Management and Diabetes Prevention Program members continue their GLP-1 treatments after one year 2 98% of members taking a GLP-1 medication continue to engage after one year 3 *This image is a fictional depiction and does not represent an actual weight-loss outcome The proof is in the progress Since starting the program in July, Ive steadily lost more than 10% of my body weight

Hamza RZ, Al-Eisa RA, El-Shenawy NS (2020) L-carnitine acts as a neuroprotecor against aspartame injury in Wistar albino rat

(extract standardized to 80% silymarin) (Sylibum Marinum)

ALL PRODUCTS ARE NOT LABELED FOR HUMAN USE OR INJECTION

Thats clearly changing

GLP-1RAs work by way of neural pathways, specifically the vagus nerve